Literature DB >> 28248943

Alzheimer disease: Antisense oligonucleotide reverses tau pathology.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2017        PMID： 28248943     DOI： 10.1038/nrd.2017.37

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.

Authors:  Brian Spencer; Ivy Trinh; Edward Rockenstein; Michael Mante; Jazmin Florio; Anthony Adame; Omar M A El-Agnaf; Changyoun Kim; Eliezer Masliah; Robert A Rissman
Journal:  Neurobiol Dis       Date:  2019-03-05       Impact factor: 5.996

2.  Computational Approach to Investigating Key GO Terms and KEGG Pathways Associated with CNV.

Authors:  YuanYuan Luo; Yan Yan; Shiqi Zhang; Zhen Li
Journal:  Biomed Res Int       Date:  2018-04-11       Impact factor: 3.411

3.  Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS.

Authors:  Howard J Rosen; Bradley F Boeve; Adam L Boxer
Journal:  Alzheimers Dement       Date:  2020-01       Impact factor: 21.566

4.  Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer's disease.

Authors:  Chenyang Han; Li Guo; Yi Yang; Qiaobing Guan; Heping Shen; Yongjia Sheng; Qingcai Jiao
Journal:  Brain Behav       Date:  2020-04-19       Impact factor: 3.405

Review 5.  Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia.

Authors:  Ruiqing Ni; Roger M Nitsch
Journal:  Front Aging Neurosci       Date:  2022-01-03       Impact factor: 5.750
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.